INOVIO (NASDAQ: INO) is set to highlight its latest research in immunotherapy at several prestigious scientific conferences this October. These presentations will focus on INO-3107, a promising ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2024-10-07 05:00:00